GPT and metabolic dysfunction-associated steatotic liver disease: The serum GPT and GOT content in the NAFLD group (195.87 ± 47.49 U/L and 156.09 ± 67.34 U/L) were significantly higher than those in the normal group (42.29 ± 10.88 U/L and 67.67 ± 15.79 U/L) (p < 0.05) (Figure 2e).